News Releases

Apr 30, 2020
Lyra Therapeutics Announces Pricing of Initial Public Offering
WATERTOWN, Mass. --(BUSINESS WIRE)--Apr. 30, 2020-- Lyra Therapeutics, Inc. (Nasdaq: LYRA) today announced the pricing of its initial public offering of 3,500,000 shares of common stock at a public offering price of $16.00 per share, before deducting underwriting discounts and commissions.
Additional Formats
Jan 29, 2020
Lyra Therapeutics Completes $30 Million Series C Financing
Proceeds to advance company’s lead product candidates for the treatment of chronic rhinosinusitis Watertown, MA  – January 29, 2020 – Lyra Therapeutics, Inc., a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for
Additional Formats
Print Page
Email Alerts
RSS Feeds
Contact IR
Search
Back to Top